Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-1989 | 04-1989 | 10-1988 | 07-1988 | 04-1988 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 473 | 976 | 1,360 | 1,576 | 576 |
| Receivables | 395 | 167 | 347 | 297 | 28 |
| Inventories | 165 | 179 | 133 | 88 | 51 |
| Other current assets | 66 | 21 | 57 | 61 | 16 |
| TOTAL | $1,099 | $1,343 | $1,897 | $2,023 | $670 |
| Non-Current Assets | |||||
| PPE Net | 936 | 942 | 834 | 808 | 751 |
| Other Non-Current Assets | 422 | 264 | 64 | 61 | 48 |
| TOTAL | $1,357 | $1,206 | $898 | $869 | $798 |
| Total Assets | $2,169 | $2,296 | $2,608 | $2,738 | $1,348 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 120 | 85 | 88 | 0 | 95 |
| Accounts payable and accrued liabilities | 177 | 211 | 110 | 143 | 228 |
| Accrued Expenses | 23 | 27 | 40 | 54 | 30 |
| Other current liabilities | 30 | 31 | 0 | 0 | 25 |
| TOTAL | $349 | $372 | $238 | $287 | $377 |
| Non-Current Liabilities | |||||
| Long Term Debt | 234 | 265 | 306 | 326 | 348 |
| Other Non-Current Liabilities | 0 | 0 | 44 | 58 | 78 |
| TOTAL | $234 | $265 | $350 | $384 | $426 |
| Total Liabilities | $583 | $637 | $544 | $614 | $726 |
| Shareholders' Equity | |||||
| Common Shares | 5 | 5 | 5 | 5 | 4 |
| Retained earnings | -1,225 | -1,152 | -729 | -683 | -760 |
| TOTAL | $1,586 | $1,659 | $2,021 | $2,067 | $545 |
| Total Liabilities And Equity | $2,169 | $2,296 | $2,564 | $2,681 | $1,271 |